Your browser doesn't support javascript.
loading
Percent decrease of serum prostate-specific antigen after dutasteride administration is equivalent in men with clinical benign prostatic hyperplasia having baseline prostate-specific antigen >10 ng/mL and those having baseline prostate-specific antigen 2.5-10 ng/mL.
Takeshita, Hideki; Kawakami, Satoru; Yano, Akihiro; Okada, Yohei; Morozumi, Makoto; Yamada, Takumi.
Afiliação
  • Takeshita H; Department of Urology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
  • Kawakami S; Department of Urology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
  • Yano A; Department of Urology, Harada Hospital, Iruma, Saitama, Japan.
  • Okada Y; Department of Urology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
  • Morozumi M; Department of Urology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
  • Yamada T; Department of Urology, Saitama Medical Center, Saitama Medical University, Kawagoe, Saitama, Japan.
Int J Urol ; 24(3): 238-239, 2017 03.
Article em En | MEDLINE | ID: mdl-28208224

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Antígeno Prostático Específico / Inibidores de 5-alfa Redutase / Dutasterida Tipo de estudo: Observational_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Int J Urol Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática / Antígeno Prostático Específico / Inibidores de 5-alfa Redutase / Dutasterida Tipo de estudo: Observational_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Int J Urol Ano de publicação: 2017 Tipo de documento: Article